SEC Form 4 · accession 0001011060-17-000028
AdvanSource Biomaterials Corp · ASNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Adams
Officer — CEO and President · Director
Period of report
Aug 23, 2017
Accepted (ET)
Aug 25, 2017 · 2:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001011060
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 23, 2017 | P | 10,000 | $0.08 | A | 609,934 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Common stock acquired through open market purchase.